The Mechanism of Action of IVIg in Inflammatory Neuropathy [ 2009 - 2015 ]

Research Grant

Researchers: Prof John Pollard (Principal investigator) ,  Dr Min-Xia Wang

Brief description Intravenous immunoglobulin (IVIg) is the major therapy used for the inflammatory neuropathies GBS, CIDP and for multifocal neuropathy. The cost of IVIg for these neuropathies in Australia is approximately 60 million dollars per year. As new indications for IVIg continue to be developed the resource becomes more valuable. We plan to explore the mechanism of action of IVIg with the aim of saving this precious resource and providing significant financial savings to the health service.

Funding Amount $AUD 452,141.15

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant